Novogen (NRT)

Stock Code


Stock Exchange


Novogen Limited (NRT) is a pharmaceutical company engaged in the development, discovery, manufacturing, and marketing of different health products using the isoflavonoid technology. NRT was listed on the Australian Stock Exchange on the 1st of September 2003. Its average annual revenue reaches approximately $17 million out of its issued capital of approximately $137 million. Its headquarters is located in North Ryde, Australia and to date; around 75 people are employed in the company.

Novogen Dividends

18 October, 2010 - 01:12

Study the list of historical dividends for Novogen. Dividends are payments made by a corporation to its shareholder members. It is the portion of corporate profits paid out to stockholders. If Novogen Limited has declared a dividend, you may be eligible to receive NRT dividends if the stock trader the company's stock on the ex-dividend date. Investors must have purchase the shares before the ex dividend date to be entitled to the dividend declared by the company. If you buy the stocks on or after the ex dividend date, the previous owner of the shares will receive the dividend.

Winner: Novogen (NRT)

The winner of the week for this week was Novogen (NRT). The stock was up nearly 50 per cent for no particular reason: which also raised an ASX query request. Novogen Limited is listed on the Australian Stock Exchange (ASX) under stock code NRT. The principal activity of the company is in pharmaceutical research and development and manufacturing and marketing of health supplements. You can view their investor website here. The company is in the Pharmaceuticals, Biotechnology & Life Sciences Industry. Check your charts!

Syndicate content

Recommended Websites